LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

Accueil・Liste d'Actions・Cara Therapeutics Inc

Cara Therapeutics Inc

Ouvert

Secteur Soins de santé

0.25 -7.41

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

0.24

Max

0.28

Chiffres clés
By Trading Economics
Ventes	3M
BPA	-0.59
Employés	55

Dividendes
By Dow Jones
Prochains Résultats	11 nov. 2024

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-2.3M 46M
Ouverture précédente	7.66
Clôture précédente	0.25

Sentiment de l'Actualité

By Acuity

21%

79%

51 / 389 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Very Strong Bullish Evidence

0.2651 / 0.2727 Support & Résistance

Cara Therapeutics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

28 oct. 2024, 23:02 UTC

Actualités

Australian Consumer-Confidence Recovery Still Intact Amid Building Rate-Cut Hopes

28 oct. 2024, 23:01 UTC

Principaux Mouvements du Marché

Lithium Americas Shares Rise After News of DOE Loan

28 oct. 2024, 22:40 UTC

Résultats

Correction to Bristol-Myers Squibb 2024 Guidance Headline on July 26

28 oct. 2024, 22:29 UTC

Résultats

Waste Management Posts Revenue Growth on Price Increases

28 oct. 2024, 23:52 UTC

Actualités

McDonald's Finds an Unlikely Savior to Finally Fix Its McFlurry Machines -- Update

28 oct. 2024, 23:42 UTC

Market Talk

Lithium Spodumene Prices Have Likely Bottomed -- Market Talk

28 oct. 2024, 23:07 UTC

Actualités

McDonald's Finds an Unlikely Savior to Finally Fix Its McFlurry Machines -- WSJ

28 oct. 2024, 23:00 UTC

Résultats

WuXi AppTec 3Q Rev CNY10.46B, Down 2% on Year >603259.SH

28 oct. 2024, 22:59 UTC

Résultats

WuXi AppTec 3Q Net CNY2.29B , Down 17% on Year >603259.SH

28 oct. 2024, 22:15 UTC

Résultats

Sandfire Resources Net Debt $345 Million at End-Sept

28 oct. 2024, 22:15 UTC

Résultats

Sandfire Resources 1Q Underlying Ebitda $121 Million

28 oct. 2024, 22:15 UTC

Résultats

Sandfire Resources 1Q Unaudited Sales Revenue $282 Million

28 oct. 2024, 22:14 UTC

Résultats

Sandfire Resources 1Q Underlying Operating Cost of $78/Ton of Ore Processed at Matsa Operation

28 oct. 2024, 22:14 UTC

Résultats

Sandfire Resources 1Q Underlying Operating Cost of $40/Ton of Ore Processed at Motheo Operation

28 oct. 2024, 22:13 UTC

Résultats

Sandfire Resources Says Copper Equivalent Output at Matsa Operation Up 4% in 1Q

28 oct. 2024, 22:13 UTC

Résultats

Sandfire Resources Reaffirms FY 2025 Output, Cost, Capex Guidance

28 oct. 2024, 22:12 UTC

Résultats

Sandfire Resources 1Q Silver Output 1.3 Million Oz, Up 9% on Quarter

28 oct. 2024, 22:12 UTC

Résultats

Sandfire Resources 1Q Lead Output 2,081 Tons, Up 9% on Quarter

28 oct. 2024, 22:12 UTC

Résultats

Sandfire Resources 1Q Zinc Output 21,542 Tons, Down 1% on Quarter

28 oct. 2024, 22:11 UTC

Résultats

Sandfire Resources 1Q Copper Output 27,012 Tons, Down 1% on Quarter

28 oct. 2024, 22:11 UTC

Résultats

Sandfire Resources 1Q Copper Equivalent Output 38,000 Tons, Flat on Quarter

28 oct. 2024, 22:07 UTC

Résultats

China Southern Airlines: Strong Travel Demand Supported Results >1055.HK

28 oct. 2024, 22:07 UTC

Résultats

China Southern Airlines 9-Mos Rev CNY134.66B Vs. CNY119.49B >1055.HK

28 oct. 2024, 22:07 UTC

Résultats

China Southern Airlines 9-Mos Net CNY1.97B Vs. Net CNY1.32B >1055.HK

28 oct. 2024, 22:01 UTC

Résultats

CMOC Group: Higher Income From Mining and Processing Segment Supported Results >3993.HK

28 oct. 2024, 22:00 UTC

Résultats

CMOC Group 3Q Rev CNY51.94B, Up 15.5% on Year >3993.HK

28 oct. 2024, 21:59 UTC

Résultats

CMOC Group 3Q Net CNY2.86B , Up 64.1% on Year >3993.HK

28 oct. 2024, 21:38 UTC

Acquisitions, Fusions, Rachats

Fomento Economico Mexicano to Sell Plastics Solutions Operations to AMMI for MXN3.17B

28 oct. 2024, 21:23 UTC

Résultats

Waste Management Raises 2024 Revenue View to Up 6% >WM

28 oct. 2024, 21:21 UTC

Résultats

Waste Management 3Q Adj EPS $1.96 >WM

Comparaison

Variation de prix

Cara Therapeutics Inc prévision

Note du Consensus

By TipRanks

0 ratings

Achat

Maintien

Vente

Basé sur 0 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Score Technique

By Trading Central

0.2651 / 0.2727Support & Résistance

Recent bullish events outweigh bearish events.

All events are bullish.

There are no events.

Sentiment

By Acuity

51 / 389Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

EBITDA

Bénéfice d'exploitation

À Propos Cara Therapeutics Inc

Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). The Company is developing a class of product candidates KORSUVA (CR845/difelikefalin), which is a KOR agonist that targets the body’s peripheral nervous system, as well as certain immune cells. The Company is also conducting preclinical studies and clinical trials of CR845/difelikefalin-based product candidates.